Anupam Rasayan India plans to go public, files Rs 760-crore IPO papers with Sebi
Anupam Rasayan Asian country|Bharat|Asian country|Asian nation} Ltd has filed a draft red herring prospectus (DRHP) with the capital market regulator Securities Exchange Board of India (SEBI). The corporate appearance to boost Rs 760-crore through Associate in Nursing initial public provide (IPO). As per the draft, net return of the problem are utilized for the compensation or payment of sure liability availed by the corporate of Rs 556.20 large integer and for general company functions. The book running lead managers to the problem are Axis Capital Ltd, orbit non-public Ltd, IIFL Securities Ltd and JM money Ltd. Whereas the registrar to Anupam Rasayan Asian nation Ltd is KFin Technologies non-public Ltd.
Anupam Rasayan engaged within the custom synthesis and producing of specialty chemicals in Asian nation. Within the financial 2020 and within the six months concluded by December 30, 2020, revenues from its life science-related specialty chemicals vertical accounted for 95.37 % and 92.48 percent, severally, of its revenue from operations, whereas revenue from alternative specialty chemicals accounted for 4.63 % and 7.52 percent, severally, of its revenue from operations, in such periods. The corporate operates six multi-purpose producing facilities in Gujarat, with four facilities set at Sachin and 2 set at Jhagadia.
Surat-based company has determined to order some for its workers and should think about a reduction for eligible employees. The corporate in the main caters to the agrochemical, tending, and pharmaceutical sectors, that accounted for over 95% of its revenues in 2019-20. Its shoppers embrace Syngenta Asia Pacific, Sumitomo Chemical Company, and UPL restricted.